Hunter Gillies serves as Executive at Aerovate Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Hunter Gillies has executed 37 insider transactions totaling $1.6M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 13, 2024 involved exercising options for 6,000 shares valued at $12.8K.
Hunter Gillies currently holds 11,602 shares of Aerovate Therapeutics, Inc. (AVTE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hunter Gillies has been a net seller of AVTE stock. They have purchased $0 and sold $1.6M worth of shares.
Hunter Gillies's most recent insider trade was on Jun 13, 2024, when they sold 6,000 shares at $2.14 per share.
Get notified when new Form 4 filings are submitted
| $24.50 |
| Planned |
| May 17, 2024 | AVTE | $8.6K | Option Exercise | 4,000 | $2.14 | Planned |
| May 17, 2024 | AVTE | $82.5K | Sale | 3,914 | $21.07 | Planned |
| May 17, 2024 | AVTE | $1.9K | Sale | 86 | $21.86 | Planned |
| Apr 17, 2024 | AVTE | $82.3K | Sale | 3,689 | $22.30 | Planned |
| Apr 17, 2024 | AVTE | $7.0K | Option Exercise | 4,000 | $1.74 | Planned |
| Apr 17, 2024 | AVTE | $7.3K | Sale | 311 | $23.33 | Planned |
| Mar 28, 2024 | AVTE | $19.3K | Option Exercise | 9,000 | $2.14 | Planned |
| Mar 28, 2024 | AVTE | $265.5K | Sale | 9,000 | $29.50 | Planned |
| Mar 18, 2024 | AVTE | $16.2K | Sale | 613 | $26.40 | Planned |
| Mar 18, 2024 | AVTE | $7.0K | Option Exercise | 4,000 | $1.74 | Planned |
| Mar 18, 2024 | AVTE | $6.4K | Option Exercise | 3,000 | $2.14 | Planned |
| Mar 18, 2024 | AVTE | $164.8K | Sale | 6,387 | $25.81 | Planned |
| Mar 7, 2024 | AVTE | $19.2K | Option Exercise | 8,975 | $2.14 | Planned |
| Mar 7, 2024 | AVTE | $219.9K | Sale | 8,975 | $24.50 | Planned |
| Feb 23, 2024 | AVTE | $10.0K | Sale | 511 | $19.50 | Planned |
| Feb 23, 2024 | AVTE | $889 | Option Exercise | 511 | $1.74 | Planned |
| Feb 20, 2024 | AVTE | $18.5K | Sale | 898 | $20.58 | Planned |
| Feb 20, 2024 | AVTE | $6.1K | Option Exercise | 3,489 | $1.74 | Planned |
| Feb 20, 2024 | AVTE | $52.1K | Sale | 2,591 | $20.11 | Planned |
| Jan 17, 2024 | AVTE | $78.0K | Sale | 4,000 | $19.50 | Planned |
| Jan 17, 2024 | AVTE | $7.0K | Option Exercise | 4,000 | $1.74 | Planned |
| Dec 27, 2023 | AVTE | $268 | Option Exercise | 125 | $2.14 | Planned |
| Dec 27, 2023 | AVTE | $3.1K | Sale | 125 | $24.50 | Planned |
| Dec 20, 2023 | AVTE | $78.0K | Sale | 4,000 | $19.50 | Planned |
| Dec 14, 2023 | AVTE | $193.0K | Sale | 9,897 | $19.50 | Planned |
| Dec 14, 2023 | AVTE | $17.2K | Option Exercise | 9,897 | $1.74 | Planned |
| Dec 13, 2023 | AVTE | $3.7K | Option Exercise | 2,103 | $1.74 | Planned |
| Dec 13, 2023 | AVTE | $41.0K | Sale | 2,103 | $19.50 | Planned |